Marina Maher Communications: Agency Business Report 2008

CEO and president Marina Maher says 2007 was a year of growth - both in business and in employees. "We invest a lot and keep people a long time," she notes. "Watching people grow was wonderful."

Outlook
CEO and president Marina Maher says 2007 was a year of growth – both in business and in employees. "We invest a lot and keep people a long time," she notes. "Watching people grow was wonderful."

The agency also launched a volunteer initiative, "MMC for a Cause," contributing to employee and agency growth.

Maher reports increased desire for social and digital media, noting that dedicated staff makes MMC well positioned to deliver.

As MMC celebrates its 25th anniversary this year, Maher feels positive about the future because clients find PR is cost effective.

Staff
Staff increased 21% in 2007 to 75 (a record high) with turnover of 14%. Headcount is over 80 this year.

Senior hires include Ellen Golden, MD, consumer practice; Kanchan Kinkade, VP, food and beverage group; and healthcare SVPs Shirley Stadtmueller and Diana Littman. Christopher Rucas, healthcare SVP, departed.

Regional performance
There was an increase in both consumer and healthcare national initiatives, with grassroots components at local levels. MMC is a Worldcom network member, giving it access to offices in 33 countries.

Practice areas
Areas are consumer (65%), healthcare (35%), and media connections, which includes traditional, social, and digital media as well as special events and graphic design, and serves both practices.

Healthcare showed "accelerated growth," led by a big win from Novo Nordisk in December. The food and beverage division grew to include wines.

Accounts
Wins include Dial, Purex, Terlato Wines International, Novo Nordisk, Galderma, and Merck's Go Red for Women Partnership. Pfizer work expanded to include the worldwide launch of TOVIAZ.

A restructuring at Procter & Gamble created a shift in accounts; for example, Dawn was lost but Aussie shampoo was gained. The firm lost business from Millenium Pharmaceuticals the company pulled PR in house.

Financial performance
Driven by both organic gains and new business wins, MMC grew 27% with both top- and bottom-line growth on revenue of less than $50 million. Performance surpassed forecast.

Principal: Marina Maher, president/CEO

Ownership: Independent

Offices: New York

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.